Mounjaro®
Starting from £179.99/mo
Start journey Learn more10mg Mounjaro sits in the upper half of the licensed dosing schedule, and for most people it represents several months of careful titration. It is not the starting point — that's 2.5mg — but it's not the ceiling either, with 12.5mg and 15mg still available. Whether 10mg feels significant depends on where you've come from. Reaching it means your prescriber has judged, dose by dose, that your body is ready to go further. These are prescription-only medicines; a clinical assessment determines which strength is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's dosing schedule is deliberately gradual. The first pen you receive delivers 2.5mg once weekly across four doses, a settling-in period designed to let your digestive system adapt rather than flood it with the medicine's full effect. After roughly a month, most people move to 5mg, then 7.5mg, then 10mg, each step taking another four weeks or so, subject to the prescriber's review.
By the time you reach 10mg, you have typically been on tirzepatide for around sixteen weeks. The question our prescribers hear fairly often at this stage is whether pushing further will make a meaningful difference. Sometimes the answer is yes; sometimes 10mg is already producing good results and a higher dose would add side-effect risk without proportionate benefit. That judgement belongs to the prescriber, not a calculator.
The 10mg Mounjaro page has more detail on what to expect from this specific pen. For a broader overview of the titration picture across all strengths, the full Mounjaro guide sets out the clinical context. The NHS medicines page for tirzepatide explains the licensed schedule and the common side-effect profile for each stage.
Each upward step increases the amount of tirzepatide reaching your receptors. At 10mg you are activating GIP and GLP-1 pathways with considerably more intensity than at, say, the 5mg level, appetite suppression tends to deepen, gastric emptying slows further, and many people find their relationship with food shifts in ways they hadn't fully anticipated on the lower doses.
That said, individual responses vary considerably. Some people notice a substantial change between 7.5mg and 10mg; others find the step less dramatic than earlier ones. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that average weight reduction continued to climb with each higher dose over 72 weeks, reaching around 20–21% at the 15mg maintenance dose, which gives some indication of the dose-response gradient, even if individual results differ from trial averages.
If you're wondering how the 10mg pen compares technically to its predecessors, the 7.5mg page walks through the same framework for that dose. It can be useful reading if you're mid-titration and curious about the pattern.
The most common side effects with tirzepatide are gastrointestinal: nausea, loose stools, constipation, reflux, and burping tend to be most noticeable after a dose increase, then usually settle over one to two weeks. At 10mg these effects are the same in character as at lower doses but may feel more pronounced, particularly in the first week of each new pen.
Staying well hydrated matters more than people sometimes expect, especially if nausea is putting you off drinking. Eating smaller portions and avoiding high-fat meals around injection day helps most people through the adjustment. If symptoms feel severe rather than just uncomfortable (or if you develop persistent, intense abdominal pain that radiates toward your back) contact your GP or NHS 111 promptly. The MHRA's Yellow Card service at yellowcard.mhra.gov.uk is also there for reporting unexpected effects.
On the subject of costs at this stage of treatment: private prices for Mounjaro do vary by dose, and it's worth reading our Mounjaro cost page before your next review so you know what to expect as you move through the schedule.
Not everyone moves beyond 10mg, and that's entirely normal. Some people reach a weight or health outcome that satisfies both them and their prescriber at this dose. Others find that 12.5mg or 15mg is needed to maintain momentum. Occasionally supply questions arise, the 10mg shortage page has current availability context if that's a concern.
The decision to increase isn't made by the calendar alone. A prescriber reviewing your case before each repeat looks at how much weight you've lost, whether side effects are manageable, and whether there are clinical reasons to pause or proceed. At nume, that review happens before every repeat order, a real prescriber reads your notes, not a script. If you're weighing up whether this dose is working well enough before moving to an earlier rung or considering the next step up, a conversation with our clinical team is the right place to start.
Starting your free consultation takes a few minutes, and if you're clinically suitable the prescription is reviewed the same day. Everything included (consultation, prescription, and next-working-day delivery) with no subscription attached. Check eligibility at our treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.